Open access
129
Views
25
CrossRef citations to date
0
Altmetric
Original Research
Comparative efficacy of long-acting β2-agonists as monotherapy for chronic obstructive pulmonary disease: a network meta-analysis
James F Donohue1 Department of Pulmonary Diseases and Critical Care Medicine, The University of North Carolina, Chapel Hill, NCCorrespondence[email protected]
, Keith A Betts2 Analysis Group, Inc., Los Angeles, CA
, Ella Xiaoyan Du2 Analysis Group, Inc., Los Angeles, CA
, Pablo Altman3 Novartis Pharmaceutical Corporation, East Hanover, NJ, USA
, Pankaj Goyal4 Novartis Pharma AG, Basel, Switzerland
, Dorothy L Keininger4 Novartis Pharma AG, Basel, Switzerland
, Jean-Bernard Gruenberger4 Novartis Pharma AG, Basel, Switzerland
& James E Signorovitch5 Analysis Group, Inc., Boston, MA, USA
show all
Pages 367-381
|
Published online: 19 Jan 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.